Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm

Journal of Nuclear Medicine

Volumn 40, Issue 7, 1999, Pages 1091-1097

  Habraken, Jan B A ^a   Booij, Jan ^b   Slomka, Piotr ^b   Sokole, Ellinor Busemann ^b   Van Royen, Eric A ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

123I labeled N fluoropropyl 2 carbomethoxy 3 (4 iodophenyl)nortropane; Automatic quantification; SPECT; Three dimensional

Indexed keywords

DOPAMINE TRANSPORTER; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)NORTROPANE I 123; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; AGED; ALGORITHM; ARTICLE; AUTOMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; LIGAND BINDING; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALGORITHMS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NORTROPANES; PARKINSON DISEASE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0032976189     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci. 1973;20:415-455.
2. Kaufman MJ, Madras BK. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum. Synapse. 1991;9:43-49.
3. Leenders KL, Salmon EP, Tyrrel P, et al. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol. 1990;47:1290-1298.
4. Innis RB, Seibyl JP, Scanley BE, et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci USA. 1993;90:1165-1169.
5. Ishikawa T, Dhawan V, Kazumata K, et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-βCIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med. 1996;37:1760-1765.
6. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol. 1993;34:423-431.
7. 123I]β-CIT: pharmacological characterization of brain uptake in non-human primates. Synapse. 1993;13:295-309.
8. Neumeyer JL, Wang S, Gao Y, et al. N-ω-fluoroalkyl analogs of (1R)-2β-carbomethoxy-3-β-(4-iodophenyl)-tropane (β-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem. 1994;37:1558-1561.
9. 123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labeling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62:133-140.
10. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
11. Tissingh G, Booij J, Bergmans P, et al. Iodine-123-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med. 1998;39:1143-1148.
12. Stoddart HA, Stoddart HF. New multi-dimensional reconstructions for the 12-detector, scanned focal point, single-photon tomograph. Phys Med Biol. 1992;37:579-586.
13. 123I]β-CIT binding with SPECT in controls, early and late Parkinson's disease. Nucl Med Biol. 1995;22:985-991.
14. Innis RB, Al-Tikriti MS, Zoghbi SS, et al. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. J Nucl Med. 1991;32:1754-1761.
15. Verhoeff NPLG, Kapucu O, Sokole-Busemann E, et al. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability. J Nucl Med. 1993;34:2076-2084.
16. Matsui T, Hirano A. An Atlas of the Human Brain for Computerized Tomography. Stuttgart, Germany: Gustav Fisher Verlag; 1978.
17. Booij J, Habraken JBA, Bergmans P, et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med. 1998;39:1879-1884.
18. Bøtcher J. Morphology of the basal ganglia in Parkinson's disease. Acta Neurol Scand. 1975; 62(suppl):1187.
19. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical Recipes: The Art of Scientific Computing. New York, NY: Cambridge University Press; 1986:289-293.
20. Seibyl JP, Laruelle M, Dyck CH. Reproducibility of iodine-123-β-CIT SPECT brain measurements of dopamine transporters. J Nucl Med. 1996;37:222-228.
21. Assenbaum S, Brücke T, Pirker W, et al. Imaging of dopamine transporters with iodine 123-β-CIT and SPECT in Parkinson's disease. J Nucl Med. 1997;38:1-6.
22. Friston KJ, Frith CD, Liddle PF, et al. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab. 1990;10:458-466.
23. Piccini P, Weeks RA, Brooks DJ. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias. Ann Neurol. 1997;42:720-726.
24. 11C-diprenorphine binding in Huntington's disease: a comparison of interest analysis with statistical parametric mapping. J Cereb Blood Flow Metab. 1997;17:943-949.
25. Borght T, Minoshima S, Giordani B, et al. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med. 1997;38:797-802.
26. Ito H, Kawashima R, Awata S, et al. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. J Nucl Med. 1996;37:410-414.
27. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E. N Engl J Med. 1996;334:752-758.
28. Kuwabara H, Cumming P, Yasuhara Y, et al. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease. J Nucl Med. 1995;36:1226-1231.
29. Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238-1248.
30. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Automatic standarization: linear scaling and nonlinear warping of functional brain images. J Nucl Med. 1994;35:1528-1537.
31. Slomka PJ, Hurwitz GA, Stephenson J, Cradduck T. Automated alignment and sizing of myocardial stress and rest scans to three-dimensional normal templates using an image registration algorithm. J Nucl Med. 1995;36:1115-1122.
32. Slomka PJ, Hurwitz GA, Clement GS, Stephenson J. Three-dimensional demarcation of perfusion zones corresponding to specific coronary arteries: application for automated interpretation of myocardial SPECT. J Nucl Med. 1995;36:2120-2128.